CD44s,CD44v5 and CD44v6 Protein Contents in Colorectal Cancer and Surrounding Mucosa

Screaton G.R. , Bell M.V. , Jackson D.G. , Cornelis F.B. , Gerth W. , Bell J.I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992; 89: 12160–4.

Jackson P.A. , Green M.A. , Pouli A. , Hubbard R. , Marks C.G. , Cook M.G. Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum. J Clin Pathol 1995; 48: 1098–101.

Gotley D.C. , Fawcett J. , Walsh M.D. , Reeder J.A. , Simmons D.L. , Antalis T.M. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br J Cancer 1996; 74: 342–51.

Mulder J.W.R. , Kruyt P.M. , Sewnath M. Colorectal cancer prognosis and expression of exon-v6 containing CD44 proteins. Lancet 1994; 344: 1470–2.

Yamaguchi A. , Urano T. , Goi T. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients. J Clin Oncol 1996; 14: 1122–7.

Wielenga V.J. , van der Voort R. , Mulder J.W. CD44 splice variants as prognostic markers in colorectal cancer. Scand J Gastroenterol 1998; 33: 82–7.

Ropponen K.M. , Eskelinen P. , Lipponen E. , Alhava E. , Kosma V.M. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand J Gastroenterol 1998; 33: 301–9.

Koretz K. , Möller P. , Lehnert T. , Hinz U. , Otto H.F. , Herfart C. Effect of CD44v6 on survival in colorectal carcinoma. Lancet 1995; 345: 327–8.

Coppola D. , Hyacinthe M. , Fu L. CD44V6 expression in human colorectal carcinoma. Hum Pathol 1998; 29: 627–35.

Finke L. , Terpe H-J , Zörb C. , Haensh W. , Schlag P.M. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1995; 345: 583.